| Short Description : | Recombinant-Human Noggin/NOG-C-His protein was developed in hek293 cells using the region Gln28-Cys232. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: | 1.Measured by its binding ability in a functional ELISA. Immobilized Human BMP2 at 1 Mu g/mL (100 Mu L/well) can bind Noggin with a linear range of 2-57 ng/mL.|2. Measured by its binding ability in a functional ELISA.Immobilized Human BMP4 at 0.5 Mu |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Gene Symbol: | NOG |
| Gene ID: | 9241 |
| Uniprot ID: | NOGG_HUMAN |
| Immunogen: | Active Recombinant Human Noggin/NOG Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln28-Cys232) of human Noggin (Accession #NP_005441.1) fused with a 6×His tag at the C-terminus. |
| Immunogen Region: | Gln28-Cys232 |
| Immunogen Sequence: | QHYLHIRPAPSDNLPLVDLI EHPDPIFDPKEKDLNETLLR SLLGGHYDPGFMATSPPEDR PGGGGGAAGGAEDLAELDQL LRQRPSGAMPSEIKGLEFSE GLAQGKKQRLSKKLRRKLQM WLWSQTFCPVLYAWNDLGSR FWPRYVKVGSCFSKRSCSVP EGMVCKPSKSVHLTVLRWRC QRRGGQRCGWIPIQYPIISE CKCSC |
Information sourced from Uniprot.org
